RMS Medical Products Announces 2019 First Quarter Financial Results

Record Quarterly Net Sales of $5.0 Million, Up 23% From Prior Year
Conference Call Scheduled for May 1 at 9:00 am ET

 

Q1 2019 Overview

  • Net sales rose 23.3% from prior year to $5.0 million – a quarterly record
  • Gross margin of 61.3%
  • HIgh-Flo Super26™ Subcutaneous Needle Sets cleared by FDA on April 5, 2019

 

 


Download Full Press Release as PDF